Cancer Stem Cells: Targeting Aldehyde Dehydrogenase 1 (ALDH1) as a Novel Strategy in Cisplatin Resistant Non-Small Cell Lung Cancer?

被引：0
|
作者：
Mac Donagh, Lauren [1 ]
Gray, Steven G. [1 ]
O'Byrne, KennethJ. [2 ]
Cuffe, Sinead [3 ]
Finn, Stephen P. [4 ,5 ]
Barr, Martin P. [6 ,7 ]
机构：
[1] Univ Dublin Trinity Coll, St Jamess Hosp, Thorac Oncol Res Grp, Dublin 2, Ireland
[2] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia
[3] St James Hosp, Hope Dept, Dublin 8, Ireland
[4] Univ Dublin Trinity Coll, Dept Pathol, Dublin 2, Ireland
[5] St James Hosp, Dublin 8, Ireland
[6] St James Hosp, Thorac Oncol, Dublin 8, Ireland
[7] Univ Dublin Trinity Coll, Dublin 2, Ireland
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Cancer Stem Cells; Cisplatin resistance; ALDH1;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ORAL42.06
引用
收藏
页码：S258 / S258
页数：1
相关论文
共 50 条
  • [1] Cancer stem cells: targeting aldehyde dehydrogenase 1 (ALDH1) as a novel strategy to overcome cisplatin resistance in NSCLC
    MacDonagh, L.
    Gray, S. G.
    Cuffe, S.
    Finn, S. P.
    O'Byrne, K. J.
    Barr, M. P.
    LUNG CANCER, 2016, 91 : S3 - S3
  • [2] Inhibition and exploitation of aldehyde dehydrogenase 1 (ALDH1) as a cancer stem cell marker in cisplatin resistant NSCLC
    Barr, M. P.
    MacDonagh, L.
    Gray, S. G.
    O'Byrne, K.
    Cuffe, S.
    Finn, S.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S87 - S87
  • [3] Aldehyde Dehydrogenase 1 (ALDH1) Expression Is Associated with Clinical Outcome in Non Small Cell Lung Cancer (NSCLC)
    Li, L.
    Sheehan, C. E.
    Ross, J. S.
    MODERN PATHOLOGY, 2010, 23 : 407A - 407A
  • [4] Aldehyde Dehydrogenase 1 (ALDH1) Expression Is Associated with Clinical Outcome in Non Small Cell Lung Cancer (NSCLC)
    Li, L.
    Sheehan, C. E.
    Ross, J. S.
    LABORATORY INVESTIGATION, 2010, 90 : 407A - 407A
  • [5] Correlation between Aldehyde Dehydrogenase 1 (ALDH1) Expression and Clinicopathologic Features in Non Small Cell Lung Cancer (NSCLC).
    Deepak, J.
    Qi, Q.
    Todd, N. W.
    Yu, L.
    Sorkin, J. D.
    Jiang, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [6] Non-small cell lung cancer cells with high ALDH1 activity display cancer stem cell properties and show chemoresistance
    Wong, S.
    Leung, E.
    Tin, V.
    Wong, M.
    CANCER RESEARCH, 2011, 71
  • [7] Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma
    Nakahata, Kengo
    Uehara, Shuichiro
    Nishikawa, Shimpei
    Kawatsu, Miyoko
    Zenitani, Masahiro
    Oue, Takaharu
    Okuyama, Hiroomi
    PLOS ONE, 2015, 10 (04):
  • [8] Aldehyde Dehydrogenase 1 (ALDH1) Promotes the Toxicity of TRAIL in Non-Small Cell Lung Cancer Cells via Post-Transcriptional Regulation of MEK-1 Expression
    Tian, Shuang
    Liu, Da-Hua
    Wang, Dan
    Ren, Fu
    Xia, Pu
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 51 (01) : 217 - 227
  • [9] Detection of Aldehyde Dehydrogenase [AlDh1] Cancer Stem Cell (CSC) marker in lung cancer and its correlation with patient prognosis
    Tiwari, N.
    Srivastava, A. N.
    Agarwal, A.
    Yadav, S.
    Venna, S. K.
    Kant, S.
    VIRCHOWS ARCHIV, 2016, 469 : S326 - S326
  • [10] Stem cell marker aldehyde dehydrogenase 1 (ALDH1)-expressing cells are enriched in triple-negative breast cancer
    Li, Huihui
    Ma, Fei
    Wang, Haijuan
    Lin, Chen
    Fan, Ying
    Zhang, Xueyan
    Qian, Haili
    Xu, Binghe
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2013, 28 (04): : E357 - E364
12345